Chinese General Practice ›› 2018, Vol. 21 ›› Issue (27): 3397-3402.DOI: 10.3969/j.issn.1007-9572.2018.00.232
Special Issue: 消化系统疾病最新文章合辑
• Monographic Research • Previous Articles Next Articles
Published:
2018-09-20
Online:
2018-09-20
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.3969/j.issn.1007-9572.2018.00.232
[1]BROWNING J D,SZCZEPANIAK L S,DOBBINS R,et al.Prevalence of hepatic steatosis in an urban population in the United States:impact of ethnicity[J].Hepatology,2004,40(6):1387-1395.DOI:10.1002/hep.20466.3400 [2]VERNON G,BARANOVA A,YOUNOSSI Z M.Systematic review:the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults[J].Aliment Pharmacol Ther,2011,34(3):274-285.DOI:10.1111/j.1365-2036.2011.04724.x.3400 [3]CLEMENTE M G,MANDATO C,POETA M,et al.Pediatric non-alcoholic fatty liver disease:recent solutions,unresolved issues,and future research directions[J].World J Gastroenterol,2016,22(36):8078-8093.DOI:10.3748/wjg.v22.i36.8078.3401 [4]LU Z Y,SHAO Z,LI Y L,et al.Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population:an 8-year follow-up study[J].World J Gastroenterol,2016,22(13):3663-3669.3401 [5]CHALASANI N,YOUNOSSI Z,LAVINE J E,et al.The diagnosis and management of non-alcoholic fatty liver disease:practice guideline by the American Gastroenterological Association,American Association for the Study of Liver Diseases,and American College of Gastroenterology[J].Gastroenterology,2012,142(7):1592-1609.DOI:10.1053/j.gastro.2012.04.001.3401 [6]WONG R J,CHEUNG R,AHMED A.Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S.[J].Hepatology,2014,59(6):2188-2195.DOI:10.1002/hep.26986.3401 [7]KUSHIYAMA A,NAKATSU Y,MATSUNAGA Y,et al.Role of uric acid metabolism-related inflammation in the pathogenesis of metabolic syndrome components such as atherosclerosis and nonalcoholic steatohepatitis[J].Mediators Inflamm,2016,2016:8603164.DOI:10.1155/2016/8603164.3401 [8]SHARAF EL DIN UAA,SALEM M M,ABDULAZIM D O.Uric acid in the pathogenesis of metabolic,renal,and cardiovascular diseases:a review[J].J Adv Res,2017,8(5):537-548.DOI:10.1016/j.jare.2016.11.004.3401 [9]MAIUOLO J,OPPEDISANO F,GRATTERI S,et al.Regulation of uric acid metabolism and excretion[J].Int J Cardiol,2016,213:8-14.DOI:10.1016/j.ijcard.2015.08.109.3401 [10]KAMOGAWA E,SUEISHI Y.A multiple free-radical scavenging(MULTIS)study on the antioxidant capacity of a neuroprotective drug,edaravone as compared with uric acid,glutathione,and trolox[J].Bioorg Med Chem Lett,2014,24(5):1376-1379.DOI:10.1016/j.bmcl.2014.01.045.3401 [11]ASHTARI F,BAHAR M,AGHAEI M,et al.Serum uric acid level in patients with relapsing-remitting multiple sclerosis[J].J Clin Neurosci,2013,20(5):676-678.DOI:10.1016/j.jocn.2012.05.054.3401 [12]SAUTIN Y Y,NAKAGAWA T,ZHARIKOV S,et al.Adverse effects of the classic antioxidant uric acid in adipocytes:NADPH oxidase-mediated oxidative/nitrosative stress[J].Am J Physiol Cell Physiol,2007,293(2):C584-596.DOI:10.1152/ajpcell.00600.2006.3401 [13]MARTYN K D,FREDERICK L M,VON LOEHNEYSEN K,et al.Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases[J].Cell Signal,2006,18(1):69-82.DOI:10.1016/j.cellsig.2005.03.023.3401 [14]张涛,迟雁青,杜春阳,等.尿酸对人肾小管上皮细胞氧化应激和TGF-β表达的影响[J].免疫学杂志,2014,30(7):585-589.DOI:10.13431/j.cnki.immunol.j.20140128.3401 ZHANG T,CHI Y Q,DU C Y,et al.Effects of uric acid on oxidative stress and TGF-β expression of human renal tubular epithelia cell[J].Immunological Journal,2014,30(7):585-589.DOI:10.13431/j.cnki.immunol.j.20140128.3401 [15]LIU C Q,HE C M,CHEN N,et al.Serum uric acid is independently and linearly associated with risk of nonalcoholic fatty liver disease in obese Chinese adults[J].Sci Rep,2016,6:38605.DOI:10.1038/srep38605.3401 [16]LIN H,LI Q,LIU X,et al.Liver fat content is associated with elevated serum uric acid in the Chinese middle-aged and elderly populations:Shanghai Changfeng Study[J].PLoS One,2015,10(10):e0140379.DOI:10.1371/journal.pone.0140379.3401 [17]LIU Z,QUE S,ZHOU L,et al.Dose-response relationship of serum uric acid with metabolic syndrome and non-alcoholic fatty liver disease incidence:a meta-analysis of prospective studies[J].Sci Rep,2015,5:14325.DOI:10.1038/srep14325.3401 [18]YU T Y,JEE J H,BAE J C,et al.Serum uric acid:a strong and independent predictor of metabolic syndrome after adjusting for body composition[J].Metabolism,2016,65(4):432-440.DOI:10.1016/j.metabol.2015.11.003.3401 [19]CAI W,SONG J M,ZHANG B,et al.The prevalence of nonalcoholic fatty liver disease and relationship with serum uric acid level in Uyghur population[J].Scientific World Journal,2014,2014:393628.DOI:10.1155/2014/393628.3401 [20]HUANG Q,YU J,ZHANG X,et al.Association of the serum uric acid level with liver histology in biopsy-proven non-alcoholic fatty liver disease[J].Biomed Rep,2016,5(2):188-192.DOI:10.3892/br.2016.698.3401 [21]WU S J,ZHU G Q,YE B Z,et al.Association between sex-specific serum uric acid and non-alcoholic fatty liver disease in Chinese adults:a large population-based study[J].Medicine(Baltimore),2015,94(17):e802.DOI:10.1097/MD.0000000000000802.3401 [22]WAN X,XU C,LIN Y,et al.Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism[J].J Hepatol,2016,64(4):925-932.DOI:10.1016/j.jhep.2015.11.022.3401 [23]LOMBARDI R,PISANO G,FARGION S.Role of serum uric acid and ferritin in the development and progression of NAFLD[J].Int J Mol Sci,2016,17(4):548.DOI:10.3390/ijms17040548.3401 [24]LI C,HSIEH M C,CHANG S J.Metabolic syndrome,diabetes,and hyperuricemia[J].Curr Opin Rheumatol,2013,25(2):210-216.DOI:10.1097/BOR.0b013e32835d951e.3401 [25]VACCA M,ALLISON M,GRIFFIN J L,et al.Fatty acid and glucose sensors in hepatic lipid metabolism:implications in NAFLD[J].Semin Liver Dis,2015,35(3):250-261.DOI:10.1055/s-0035-1562945.3401 [26]ZHI L,YUZHANG Z,TIANLIANG H,et al.High uric acid induces insulin resistance in cardiomyocytes in vitro and in vivo[J].PLoS One,2016,11(2):e0147737.DOI:10.1371/journal.pone.0147737.3401 [40]GOPAL K,JOHNSON T C,GOPAL S,et al.Correlation between beta-lipoprotein levels and outcome of hepatitis C treatment[J].Hepatology,2006,44(2):335-340.DOI:10.1002/hep.21261.3402 [41]GIRELLI D,PASINO M,GOODNOUGH J B,et al.Reduced serum hepcidin levels in patients with chronic hepatitis C[J].J Hepatol,2009,51(5):845-852.DOI:10.1016/j.jhep.2009.06.027.3402 [42]GOPAL K,JOHNSON T C,GOPAL S,et al.Correlation between beta-lipoprotein levels and outcome of hepatitis C treatment[J].Hepatology,2006,44(2):335-340.DOI:10.1002/hep.21261.3402 [43]BODLAJ G,HUBMANN R,SALEH K,et al.Alkaline phosphatase predicts relapse in chronic hepatitis C patients with end-of-treatment response[J].World J Gastroenterol,2010,16(19):2407-2410.DOI:10.3748/wjg.v16.i19.2407.3402 [44]EZZIKOURI S,KIMURA K,SUNAGOZAKA H,et al.Serum DHCR24 auto-antibody as a new biomarker for progression of hepatitis C[J].EBioMedicine,2015,2(6):604-612.DOI:10.1016/j.ebiom.2015.04.007.3402 [45]SAITO M,YANO Y,HIRANO H,et al.Serum NX-DCP as a new noninvasive model to predict significant liver fibrosis in chronic hepatitis C[J].Hepat Mon,2015,15(2):e22978.DOI:10.5812/hepatmon.22978.3402 [27]AVULA N R,SHENOY D.Evaluation of association of hyperuricaemia with metabolic syndrome and insulin resistance[J].J Clin Diagn Res,2016,10(12):OC32-34.DOI:10.7860/JCDR/2016/22182.9113.3402 [28]TAKIR M,KOSTEK O,OZKOK A,et al.Lowering uric acid with allopurinol improves insulin resistance and systemic inflammation in asymptomatic hyperuricemia[J].J Investig Med,2015,63(8):924-929.DOI:10.1097/JIM.0000000000000242.3402 [29]LANASPA M A,SANCHEZ-LOZADA L G,CHOI Y J,et al.Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress:potential role in fructose-dependent and -independent fatty liver[J].J Biol Chem,2012,287(48):40732-40744.DOI:10.1074/jbc.M112.399899.3402 [30]CHOI Y J,SHIN H S,CHOI H S,et al.Uric acid induces fat accumulation via generation of endoplasmic reticulum stress and SREBP-1c activation in hepatocytes[J].Lab Invest,2014,94(10):1114-1125.DOI:10.1038/labinvest.2014.98.3402 [31]SOZEN E,OZER N K.Impact of high cholesterol and endoplasmic reticulum stress on metabolic diseases:an updated mini-review[J].Redox Biol,2017,12:456-461.DOI:10.1016/j.redox.2017.02.025.3402 [32]DE TORRE-MINGUELA C,MESA DEL CASTILLO P,PELEGRN P.The NLRP3 and pyrin inflammasomes:implications in the pathophysiology of autoinflammatory diseases[J].Front Immunol,2017,8:43.DOI:10.3389/fimmu.2017.00043.3402 [33]CAI C,ZHU X,LI P,et al.NLRP3 deletion inhibits the non-alcoholic steatohepatitis development and inflammation in kupffer cells induced by palmitic acid[J].Inflammation,2017,40(6):1875-1883.DOI:10.1007/s10753-017-0628-z.3402 [34]WAN X,XU C,LIN Y,et al.Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism[J].J Hepatol,2016,64(4):925-932.DOI:10.1016/j.jhep.2015.11.022.3402 [35]RONCAL-JIMENEZ C A,LANASPA M A,RIVARD C J,et al.Sucrose induces fatty liver and pancreatic inflammation in male breeder rats independent of excess energy intake[J].Metabolism,2011,60(9):1259-1270.DOI:10.1016/j.metabol.2011.01.008.3402 [36]JOHNSON R J,NAKAGAWA T,SANCHEZ-LOZADA L G,et al.Sugar,uric acid,and the etiology of diabetes and obesity[J].Diabetes,2013,62(10):3307-3315.DOI:10.2337/db12-1814.3402 [37]ISHIMOTO T,LANASPA M A,LE M T,et al.Opposing effects of fructokinase C and A isoforms on fructose-induced metabolic syndrome in mice[J].Proc Natl Acad Sci U S A,2012,109(11):4320-4325.DOI:10.1073/pnas.1119908109.3402 [38]LANASPA M A,SANCHEZ-LOZADA L G,CICERCHI C,et al.Uric acid stimulates fructokinase and accelerates fructose metabolism in the development of fatty liver[J].PLoS One,2012,7(10):e47948.DOI:10.1371/journal.pone.0047948.3402 [39]旷历琼,王娜.中老年非酒精性脂肪肝患者临床特点及其与血脂、血尿酸水平的相关性分析[J].疑难病杂志,2014,13(10):1012-1014.DOI:10.3969/j.issn.1671-6450.2014.10.08.3402 KUANG L Q,WANG N.The characters of nonalcoholic fatty liver disease and the related risk factors with blood lipid and serum uric acid[J].Chinese Journal of Difficult and Complicated Cases,2014,13(10):1012-1014.DOI:10.3969/j.issn.1671-6450.2014.10.08.3402 [40]高锦凤,宋镇,何方平,等.非酒精性脂肪性肝病与尿酸水平和肾功能损伤的相关性研究[J].疑难病杂志,2010,9(7):518-520.DOI:10.3969/j.issn.1671-6450.2010.07.018.3402 GAO J F,SONG Z,HE F P,et al.Relationship between uric acid level and renal function impairment in nonalcoholic fatty liver disease[J].Chinese Journal of Difficult and Complicated Cases,2010,9 (7):518-520.DOI:10.3969/j.issn.1671-6450.2010.07.018.3402 |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||